Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 1052-1062

  Strojan, Primož ^a   Budihna, Marjan ^a   Šmid, Lojze ^b   Svetic, Branka ^a   Vrhovec, Ivan ^a   Kos, Janko ^c,d   Škrk, Janez ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b Univ Dept Otorhinolaryngology C   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d KRKA D D   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN L; STEFIN A; STEFIN B;

ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; ENZYME LOCALIZATION; FEMALE; FOLLOW UP; HEAD CANCER; HUMAN; MALE; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CATHEPSIN B; CATHEPSINS; CYSTATINS; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034059284     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Agarwal, S. K. Proteases cathepsins - a view. Biochem. Educ., 18: 67-72, 1990.
2. Turk, V., and Bode, W. Human cysteine proteinases and their inhibitors, stefins and cystatins. In: F. X. Aviles (ed.), Innovations in Proteases and Their Inhibitors, pp. 47-59. Berlin: Walter de Gruyter, 1993.
3. Kos. J., and Lah, T. T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol. Rep., 5: 1349-1361, 1998.
4. Andreasen, P. A., Kjoller, L., Christensen, L., and Duffy, M. J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer, 72: 1-22, 1997.
5. Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Gunzler, W. A., Janicke, F., and Graeff, H. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J. Biol. Chem., 266: 5147-5152, 1991.
6. Goretzki, L., Schmitt, M., Mann, K., Calvete, J., Chucholowski, N., Kramer, M., Gunzler, W. A., Janicke, F., and Graeff, H. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L. FEBS Lett., 297: 112-118, 1992.
7. Dalet-Fumeron, V., Guinec, N., and Pagano, M. In vitro activation of pro-cathepsin B by three serine proteinases: leucocite elastase, cathepsin G, and the urokinase-type plasminogen activator. FEBS Lett., 332: 251-254, 1993.
8. Nishimura, Y., Kawabata, T., and Kato, K. Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch. Biochem. Biophys., 261: 64-71, 1988.
9. Rowan, A. D., Mason, P., Mach, L., and Mort, J. S. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J. Biol. Chem., 267: 15993-15999, 1992.
10. Menard, R., Carmona, E., Takebe, S., Dufour, E., Plouffe, C., Mason, P., and Mort, J. S. Autocatalytic processing of recombinant human procathepsin L. Contribution of both intermolecular and unimolecular events in the processing of procathepsin L in vitro. J. Biol. Chem., 273: 4478-4484, 1998.
11. Rochefort, H., Liaudet, M., and Garcia, M. Alterations and role of human cathepsin D in cancer metastasis. Enzyme Protein, 49: 106-116, 1996.
12. Buck, M. R., Karustis, D. G., Day, N. A., Honn, K. V., and Sloane, B. F. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J., 282: 2273-2278, 1992.
13. Mason, R. W., Johnson, D. A., Barrett A. J., and Chapman, H. A. Elastinolytic activity of human cathepsin L. Biochem. J., 233: 925-927, 1986.
14. r 52,000 cathepsin D secreted by breast cancer cells. Cancer Res., 48: 3688-3692, 1988.
15. Kos, J., Štabuc, B., Schweiger, A., Krašovec, M., Cimerman, N., Kopitar-Jerala, N., and Vrhovec, I. Cathepsins B, H, and L, and their inhibitors stefin A, and cystatin C in sera of melanoma patients. Clin. Cancer Res., 3: 1815-1822, 1997.
16. Budihna, M., Škrk, J., Zakotnik, B., Gabrijelčič, D., and Lindtner, J. Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast. Eur. J. Cancer, 31A: 661-664, 1995.
17. Thomssen, C., Schmitt, M., Goretzki L., Oppelt, P., Pache, L., Dettmar, P., Jänicke, F., and Graef, H. Prognostic value of the cysteine proteases cathepsin B and cathepsin L in human breast cancer. Clin. Cancer Res., 1: 741-746, 1995.
18. Lah, T. T., Kos, J., Blejec, A., Frkovič-Georgio, S., Golouh, R., Vrhovec, I., and Turk, V. The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease. Pathol. Oncol. Res., 3: 89-99, 1997.
19. Foekens, J. A., Kos, J., Peters, H. A., Krašovec, M., Look, M. P., Cimerman, N., Meijer-van Gelder, M. E., Henzen-Logmans, S. C., van Putten, W. L. J., and Klijn, J. G. M. Prognostic significance of cathepsins B and L in primary human breast cancer. J. Clin. Oncol., 16: 1013-1021, 1998.
20. Thomssen, C., Oppelt, P., Jänicke, F., Ulm, K., Harbeck, N., Höfler, H., Kuhn, W., Graef, H., and Schmitt, M. Identification of low-risk node-negative breast cancer patients by turnor biological factors PAI-1 and cathepsin L. Anticancer Res., 18: 2173-2180, 1998.
21. Kuopio, T., Kankaanranta, A., Jalava, P., Kronqvist, P., Kotkansalo, T., Weber, E., and Collan, Y. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res., 58: 432-436, 1998.
22. Campo, E., Munoz, J., Miquel, R., Palacin, A., Cardesa, A., Sloane, B. F., and Emmert-Buck, M. R. Cathepsin B expression in colorectal carcinoma correlates with tumor progression and shortened patient survival. Am. J. Pathol., 145: 301-309, 1994.
23. Kos, J., Nielsen, H. J., Krašovec, M., Christensen, I. J., Cimerman, N., Stephens, R. W., and Brünner, N. Prognostic value of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin. Cancer Res., 4: 1511-1516, 1998.
24. Inoue, T., Ishida, K., Sugio, K., and Sugimachi, K. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res., 54: 6133-6136, 1994.
25. Knoch, H., Werle, B., Ebert, W., and Spiess, E. Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int. J. Oncol., 5: 77-85, 1994.
26. Werle, B., Julke, B., Lah, T., Kos, J., Spiess, E., and Ebert, W. Cathepsin B and cathepsin L: prognostic factors in human lung cancer. In: V. K. Hopsu-Havu, M. Jarvinen, and H. Kirschke (eds.), Proteolysis in Cell Function, pp. 472-478. Amsterdam: IOS Press, 1997.
27. Ebert, E., Werle, B., Jülke, B., Kopitar-Jerala, N., Kos, J., Lah, T., Abrahamson, M., Spiess, E., and Ebert, W. Expression of cysteine proteinase inhibitors stefin A, stefin B and cystatin C in human lung tumors. Adv. Exp. Med. Biol., 421: 259-265, 1997.
28. Plebani, M., Herszenyi, L., Cardin, R., Roveroni, G., Carraro, P., Paoli, M. D., Rugge, M., Grigioni, W. F., Nitti, D., Naccarato, R., and Farinati, F. Cysteine and serine proteases in gastric cancer. Cancer (Phila.), 76: 367-375, 1995.
29. Strojnik, T., Kos, J., Židanik, B., Golouh, R., and Lah, T. Cathepsin B immunohistochemical staining in tumor and endotelial cells is a new prognostic factor for survival in patients with brain tumors. Clin. Cancer Res., 5: 559-567, 1999.
30. Siewiński, M., Krȩcicki, T., Jarmulowicz, J., and Berdowska, I. Cysteine proteinase inhibitors in serum of patients with head and neck cancer. Diagn. Oncol., 2: 323-326, 1992.
31. Krȩcicki, T., and Siewinski, M. Serum cathepsin B-like activity as a potential marker of laryngeal carcinoma. Eur. Arch. Oto-Rhino-Laryngol., 249: 293-295, 1992.
32. Bongers, V., Konings, C. H., Grijpma, A. M., Steen, I., Braakhuis, B. J. M., and Snow, G. B. Serum proteinase activities in head and neck squamous cell carcinoma patients. Anticancer Res., 15: 2763-2766, 1995.
33. Russo, A., Bazan, V., Gebbia, N., Pizzolanti, G., Tumminello, F. M., Dardanoni, G., Ingria, F., Restivo, S., Tomasino, R. M., and Leto, G. Flow cytometric DNA analysis and lysosomal cathepsins B and L in locally advanced laryngeal cancer. Cancer (Phila.), 76: 1757-1764, 1995.
34. Budihna, M., Strojan, P., Šmid, L., Škrk, J., Vrhovec, I., Župevc, A., Rudolf, Z., Žargi, M., Krašovec, M., Svetic, B., Kopitar-Jerala, N., and Kos, J. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol. Chem. Hoppe-Seyler, 377: 385-390, 1996.
35. Šmid, L., Strojan, P., Budihna, M., Škrk, J., Vrhovec, J., Žargi, M., and Kos, J. Prognostic value of cathepsins B, L and stefins A and B in laryngeal carcinoma. Eur. Arch. Otolaryngol., 254: 150-153, 1997.
36. Strojan, P., Budihna, M., Šmid, L., Svetic, B., Vrhovec, I., Kos, J., and Škrk, J. Cathepsin H in squamous cell carcinoma of the head and neck. Radiol. Oncol., in press, 1999.
37. Sobin, L. H., and Wittekind, Ch. TNM Classification of Malignant Tumours. International Union Against Cancer (UICC), Ed. 5, pp. 20-37. New York: Wiley-Liss, 1997.
38. Azzopardi, J. G., Chepizk, O. F., and Hartman, W. H. International Histological Classification of Tumours No.2: Histological Typing of Breast Tumours, Ed 2. Geneva: World Health Organization, 1981.
39. Bradford, M. A rapid sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
40. Kos, J., Šmid, A., Krašovec, M., Svetic, B., Lenarčič, B., Vrhovec, I., Škrk, J., and Turk, V. Lysosomal proteinases cathepsins D, B. H, L and their inhibitors stefins A and B in head and neck cancer. Biol. Chem. Hoppe-Seyler, 376: 401-405, 1995.
41. Jerala, R., Žerovnik, E., Lohner, K., and Turk, V. Structural basis for the difference in thermodynamic properties between the two cysteine proteinase inhibitors human stefins A and B. Protein Eng., 7: 977-984, 1994.
42. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc., 53: 457-481, 1958.
43. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., and Smith, P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35: 1-39, 1977.
44. Altman, D. G., Lausen, B., Sauerbrei, W., and Schumacher, M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J. Natl. Cancer Inst., 86: 829-835, 1994.
45. Cox, D. R. Regression models and life tables. J. R. Stat. Soc., 187: 187-220, 1972.
46. Strojan, P. Cathepsins and their endogenous inhibitors in clinical oncology. Radiol. Oncol., 30: 120-133, 1996.
47. Borštnar, S., Čufer, T., and Rudolf, Z. The urokinase-type plasminogen activator, its inhibitors and its receptor - the new prognostic factors in solid cancers. Radiol. Oncol., 31: 298-304, 1997.
48. Strojan, P., Budihna, M., Šmid, L., Vrhovec, I., and Škrk, J. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Cancer Lett., 130: 49-56, 1998.
49. Strojan, P., Budihna, M., Šmid, L., Vrhovec, I., and Škrk, J. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients. Eur. J. Cancer, 34: 1193-1197, 1998.
50. Werle, B., Jülke, B., Lah, T., Spiess, E., and Ebert, W. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung. Br. J. Cancer, 75: 1137-1143, 1997.
51. Lah, T. T., Clifford, J. L., Helmer, K. M., Day, N. A., Moin, K., Honn, K. V., Crissman, J. D., and Sloane, B. F. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim. Biophys. Acta, 993: 63-73, 1989.
52. Heidtmann, H. H., Salge, U., Abrahamson, M., Benčina, M., Kastelic, L., Kopitar-Jerala, N., Turk, V., and Lah, T. T. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Clin. Exp. Metastasis. 15: 368-381, 1997.